We are live on ! Find out more
Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Portfolio holdings

AUM $44.6B
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
+9.23%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$26B
AUM Growth
+$2.52B
Cap. Flow
+$734M
Cap. Flow %
2.83%
Top 10 Hldgs %
21.08%
Holding
3,430
New
246
Increased
1,548
Reduced
1,426
Closed
128

Sector Composition

Rank Sector Weight
1 Technology 10.99%
2 Financials 5.01%
3 Consumer Discretionary 4.04%
4 Healthcare 3.7%
5 Industrials 2.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CUTR
3226
DELISTED
Cutera, Inc.
CUTR
$43K ﹤0.01%
+29,054
New +$75.4K
CUE icon
3227
Cue Biopharma
CUE
$128M
$42K ﹤0.01%
740
PRPL icon
3228
Purple Innovation
PRPL
$28.4M
$42K ﹤0.01%
957
+160
+20% +$5.33K
LEV
3229
DELISTED
The Lion Electric Company
LEV
$42K ﹤0.01%
29,650
-1,869
-6% -$3.02K
DHX icon
3230
DHI Group
DHX
$166M
$41K ﹤0.01%
+16,000
New +$39.9K
SOHO
3231
DELISTED
Sotherly Hotels
SOHO
$41K ﹤0.01%
28,208
NG icon
3232
NovaGold Resources
NG
$3.45B
$40K ﹤0.01%
+13,449
New +$37.9K
NAK
3233
Northern Dynasty Minerals
NAK
$953M
$38K ﹤0.01%
119,060
+32,000
+37% +$8.82K
PHX
3234
DELISTED
PHX Minerals
PHX
$38K ﹤0.01%
11,170
-791
-7% -$2.47K
PGRU
3235
DELISTED
PropertyGuru Group Limited
PGRU
$38K ﹤0.01%
10,055
-570
-5% -$1.97K
ASRT
3236
DELISTED
Assertio
ASRT
$37K ﹤0.01%
2,599
+1,270
+96% +$17.3K
OXSQ icon
3237
Oxford Square Capital
OXSQ
$166M
$37K ﹤0.01%
11,711
+370
+3% +$1.13K
LAZR
3238
DELISTED
Luminar Technologies
LAZR
$36K ﹤0.01%
1,204
+91
+8% +$3.32K
LDI icon
3239
loanDepot
LDI
$298M
$35K ﹤0.01%
+13,435
New +$36.1K
EMX
3240
DELISTED
EMX Royalty
EMX
$34K ﹤0.01%
19,896
-5,313
-21% -$8.41K
BRFS
3241
DELISTED
BRF SA
BRFS
$33K ﹤0.01%
10,000
HYPD
3242
Hyperion DeFi Inc
HYPD
$40.8M
$33K ﹤0.01%
+414
New +$56.3K
LONA
3243
LeonaBio Inc
LONA
$73.9M
$32K ﹤0.01%
+1,178
New +$37.4K
CERS icon
3244
Cerus
CERS
$546M
$32K ﹤0.01%
+17,110
New +$34.9K
OPEN icon
3245
Opendoor
OPEN
$3.39B
$31K ﹤0.01%
10,491
-864
-8% -$2.7K
HRTX icon
3246
Heron Therapeutics
HRTX
$64.7M
$30K ﹤0.01%
10,867
-1,000
-8% -$2.51K
KOPN icon
3247
Kopin
KOPN
$930M
$29K ﹤0.01%
+15,940
New +$35.4K
OTLY
3248
Oatly Group
OTLY
$420M
$28K ﹤0.01%
1,237
-10
-0.8% -$225
OPTU
3249
Optimum Communications Inc
OPTU
$227M
$27K ﹤0.01%
10,327
DHC
3250
Diversified Healthcare Trust
DHC
$2.02B
$27K ﹤0.01%
10,877
-4,961
-31% -$14.2K

Similar funds

Cambridge Investment Research Advisors's Q1 2024 Portfolio in Review

As of Q1 2024, Cambridge Investment Research Advisors held 3,430 positions worth $26B, up 11% from $23.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Cambridge Investment Research Advisors's Q1 2024 filing shows 246 new, 1,548 increased, 1,426 reduced and 128 closed positions. Its largest new stake was Polen Capital International Growth ETF: 1,886,311 shares worth $18.9M. The largest sale was Apple, an estimated $25M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Cambridge Investment Research Advisors's largest Q1 2024 buy was Polen Capital International Growth ETF: 1,886,311 shares worth $18.9M.
  • Cambridge Investment Research Advisors added most to Vanguard Total Bond Market in Q1 2024, an estimated $25.4M increase.
  • Cambridge Investment Research Advisors's biggest Q1 2024 reduction was Apple, cutting an estimated $25M.
  • Cambridge Investment Research Advisors fully exited iMGP RBA Responsible Global Allocation ETF in Q1 2024, selling an estimated $3.97M.
  • Cambridge Investment Research Advisors's ten largest holdings make up 21% of its $26B portfolio in Q1 2024.
  • Cambridge Investment Research Advisors opened 246 new positions and closed 128 in Q1 2024.
  • Cambridge Investment Research Advisors's portfolio value rose 11% quarter-over-quarter to $26B.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2024, filed 24 Apr 2024.